Pharmaceutical Method-of-Use Claims After Teva v. Eli Lilly and In re Xencor: Written Description, Enablement, and the Known-Compound Genus

Introduction Two recent Federal Circuit decisions offer complementary guidance on a recurring question in patent law: what must a patent specification disclose to satisfy written description and…